Author:
Vos Miriam B.,Van Natta Mark L.,Blondet Niviann M.,Dasarathy Srinivasan,Fishbein Mark,Hertel Paula,Jain Ajay K.,Karpen Saul J.,Lavine Joel E.,Mohammad Saeed,Miriel Laura A.,Molleston Jean P.,Mouzaki Marialena,Sanyal Arun,Sharkey Emily P.,Schwimmer Jeffrey B.,Tonascia James,Wilson Laura A.,Xanthakos Stavra A.,
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference45 articles.
1. NASPGHAN Clinical Practice Guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN);J Pediatr Gastroenterol Nutr,2017
2. In children with nonalcoholic fatty liver disease, zone 1 steatosis is associated with advanced fibrosis;Clin Gastroenterol Hepatol,2018
3. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels;J Pediatr,2014
4. Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease;JAMA Pediatr,2016
5. Progression of fatty liver disease in children receiving standard of care lifestyle advice;Gastroenterology,2020
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献